A Pharmacoeconomic Evaluation of the Use of Dexrazoxane in Preventing Anthracycline-Induced Cardiotoxicity in Patients with Stage IIIB or IV Metastatic Breast Cancer
- 1 February 1997
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (1) , 167-184
- https://doi.org/10.1016/s0149-2918(97)80084-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: